is an ignored dermatological entity. Nowadays it occurs more frequently than previous days may be due to changing economic and social status of our country. Aim of this study was to assess the rate of metabolic syndrome in cases of facial acanthosis nigricans. is observational study was conducted in the outpatient department (OPD) of dermatology and Venereology of Bangabandhu Sheikh Mujib Medical University (BSMMU) in the year 2017 among thirty clinically diagnosed cases of FAN. After taking their informed written consent; BMI, random plasma glucose, fasting lipid pro le and serum insulin level was estimated in venous blood and recorded accordingly. To con rm metabolic syndrome we followed NCEP ATP III guideline (2005) where 3 of 5 positive criteria con rmed the diagnosis. All data was preserved in a secured computer device and was analyzed with SPSS program with appropriate statistical tools. Mean (±SD) age of patients was 35.63 ± 14.26 years and male to female ratio was 1:1.14. e mean BMI of cases was 33.73±3. We found 11 cases with hypertension, 8 with type II diabetes mellitus and 9 with dyslipidemia. Among the 30 cases of FAN 12 zygomatic type, 8 generalized type and 5 had band like pigmentation on the forehead. Twenty-three patients had acanthosis nigricans on both sides of body. According to our preset criteria we found 26.66% cases had metabolic syndrome. e rate of metabolic syndrome is higher in facial acanthosis nigricans patients. A further large scale study is recommended for strengthening this study ndings.
INTRODUCTION
Acanthosis nigricans (AN) is a simply identi able dermatological condition characterized by velvety-dark coloured plaques appears on folds of skin, hands and feet, groin, armpits, umbilical area, knuckles, along the neck and even mucosal surface. 1 It presented as brown-to-black macular pigmentation with blurred ill-de ned margins, commonly found on the zygomatic and malar areas with varying degrees of textural changes ranging from mild roughness to frank verrucous appearance of the a ected areas. 2 Stimulation of tyrosine kinase growth factor receptor signaling pathways in epidermis is considered as common mechanism of AN. 3 It is known for over hundred years, initially it thought to be a rare skin condition; but with the increasing rate of obesity and type-2 diabetes it is now a relatively common. 4 e rate of occurrence of AN among di erent ethnic groups varies from 7% to 49.2%. [5] [6] [7] AN is frequently associated with obesity, endocrine disorders (type 2 diabetes mellitus, isulin-resistance and hyperinsulinemia, hypothyroidism, hyperthyroidism and cushing syndrome), malignancy, genetic syndromes and the use of some drugs (glucocorticoids, niacin, insulin, oral contraceptives, and protease inhibitors), insulin injections (especially at the injection site). [8] [9] [10] [11] Facial AN is not a very common entity although some patients present with facial involvement. It is one of many causes of facial melanosis accounting 7.5%. 12 e initial common manifestation of facial acanthosis nigricans are cutaneous dryness, dark coloration and coarseness, which in a ected area is of slate or black colored. 13 e pigmentation is followed by hypertrophy, accentuation of skin marking, and velvety texture. 13 Table I summarizes two commonly used de nitions of metabolic syndrome. National Cholesterol Education Program (NCEP) Adult Treatment Panel-III(ATP-III)2005 was set ve criteria for de ne metabolic syndrome. Obesity, hyperglycemia, dyslipidemia, hypertension any three of that ve points will con rm metabolic syndrome. e World Health Organization (WHO) rst developed its de nition in 1998. Because insulin resistance was felt to be central to the pathophysiology of metabolic syndrome, evidence for insulin resistance is an absolute requirement in the WHO de nition. In addition to this absolute requirement for insulin resistance, two additional criteria have to be met. ese include obesity, dyslipidemia, hypertension and microalbuminuria.
MATERIALS AND METHODS
Clinically con rmed cases of facial acanthosis nigricans (FAN) who ful lled our inclusion and exclusion criteria was enlisted as our case. Written consent was taken before taking personal and clinical information. Weight and height of patients was taken with a weight machine and abdominal circumference was measured with a plastic measuring tape. Blood pressure was measured with a sphygmomanometer and stethoscope. Patient's venous blood (5 cc) was drawn with aseptic measures and was sent for biochemical test of fasting lipid pro le and fasting blood glucose.We de ned metabolic syndrome according to National Cholesterol Education Program (NCEP) Adult Treatment Panel-III (ATP-III)2005 criteria. Where obesity was established when waist circumference of a male was more than 40 inches and that of female was more than 35 
RESULTS
Out of 30 patients with facial acanthosis nigricans 14 (46.67%) were male and 16 (53.33%) were female mean age of cases was 35.63 years and their minimum age was 16 years and maximum age was 62 years. Regarding facial acanthosis nigricans we found 5 types of pigmentation like generalized, zygomatic, periorbital, band like on forehead and darkening over sulcus alaris nasi and sulcus mentolabialis. In our study zygomatic pigmentation was more common 40% than generalized (26.66%) and band like ogumentation on forehead type (16.66%).
We de ned metabolic syndrome according to NCEP ATP III. We found waist circumference was high in (43.33%) cases, systemic hypertension was found in 36.66% cases, hyperglycemia in 26.66%, hypertriglyceridaemia in 30% cases and low HDL level in 26.7% cases. We found 8 (26.7%) patients with metabolic syndrome, who ful lled at least three of above mentioned ve criteria. Of them 16.66% was male and 10% was female respondent. In a similar study conducted on 139 FAN patients found mean (±SD) age was 38.8 ±8.6 years and age range was 39 (22-61) years. 15 According to NCEP ATP III guideline we de ned metabolic syndrome with 5 clinical and/or biochemical points. We looked for abdominal obesity while waist circumference became >40 inches in male and > 35 inches in case of female it was de ned as obesity level. In our study 13 (43.3%) was positive for central obesity. 21 Hypertension was found in 11 (36.7%) cases, hyperglycemia was found in 8 (26.7%) cases, hypertriglyceridemia was found in 9 (30%) cases and low HDL level was found in 8 (26.7%) cases. Panda et al. found obesity in 39.84% cases, hypertension 22.8% case and dyslipidaemia in 39.0% cases. Outcome of that study was similar to our ndings.
Panda et.al. found that obese patient classi ed as per BMI were increased chance to develop FAN two times than normal. In our study we found 26.7% cases with FAN developed metabolic syndrome.
CONCLUSIONS
In our study we found rate of metabolic syndrome is more in patients with FAN in our community. We suggest a large scale study to support and verify our study out comes.
